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Background: The Global Programme to Eliminate Lymphatic Filariasis (GPELF) was launched in 2000, and nearly all
endemic countries in the Americas, Eastern Mediterranean and Asia-Pacific regions have now initiated the WHO
recommended mass drug administration (MDA) campaign to interrupt transmission of the parasite. However, nearly
50% of the LF endemic countries in Africa are yet to implement the GPELF MDA strategy, which does not include
vector control. Nevertheless, the recent scale up in insecticide treated /long lasting nets (ITNs/LLINs) and indoor
residual spraying (IRS) for malaria control in Africa may significantly impact LF transmission because the parasite is
transmitted mainly by Anopheles mosquitoes. This study examined the magnitude, geographical extent and
potential impact of vector control in the 17 African countries that are yet to or have only recently started MDA.
Methods: National data on mosquito bed nets, ITNs/LLINs and IRS were obtained from published literature,
national reports, surveys and datasets from public sources such as Demographic Health Surveys, Malaria Indicator
Surveys, Multiple Indicator Cluster Surveys, Malaria Report, Roll Back Malaria and President’s Malaria Initiative
websites. The type, number and distribution of interventions were summarised and mapped at sub-national level.
and compared with known or potential LF distributions, and those which may be co-endemic with Loa loa and
MDA is contraindicated.
Results: Analyses found that vector control activities had increased significantly since 2005, with a three-fold
increase in ITN ownership and IRS coverage. However, coverage varied dramatically across the 17 countries; some
regions reported >70% ITNs ownership and regular IRS activity, while others had no coverage in remote rural
populations where the risk of LF was potentially high and co-endemic with high risk L.loa.
Conclusions: Despite many African countries being slow to initiate MDA for LF, the continued commitment and
global financial support for NTDs, and the concurrent expansion of vector control activities for malaria, is promising.
It is not beyond the capacity of GPELF to reach its target of global LF elimination by 2020, but monitoring and
evaluating the impact of these activities over the next decade will be critical to its success.
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The Global Programme to Eliminate Lymphatic Filariasis
(GPELF) has made remarkable progress since its incep-
tion in 2000, and is hailed to be the most rapidly
expanding global health programme in history [1,2].
Nearly all 39 endemic countries in the Americas, Eastern
Mediterranean and Asia-Pacific regions have initiated
or finished the World Health Organization (WHO)
recommended mass drug administration (MDA) cam-
paign to interrupt transmission of the two main parasites,
Wuchereria bancrofti and/or Brugia malayi with signifi-
cant scale-up in drug distributions and reductions in dis-
ease burden being demonstrated [1,2].
This progress is promising for GPELF and its goal of
LF elimination by 2020 [1]. However, for all countries to
fully benefit from this global effort, it must address the
slow progress in Africa where half of the 34 endemic
countries have not or have only just started to imple-
ment the GPELF intervention strategy for LF elimin-
ation, which does not promote vector control, despite
the suggestion of the need to link malaria and LF activ-
ities for mutual benefit [3-5], and the widespread evi-
dence of the value of vector control in the control/
elimination of LF [6,7].
The African continent has a large burden of LF, which
is caused by the parasite W. bancrofti and predominantly
transmitted by Anopheles mosquitoes in rural areas and
by Culex in urban and coastal areas of East Africa
[7-12]. While many countries have started MDA and
made steady progress over the past decade, at the half
way mark of GPELF in 2010 [1,13], there were still 17
endemic countries that had not started MDA activities for
LF elimination. These countries included Angola, Central
Africa Republic (CAR), Chad, Congo, Democratic Republic
of Congo (DRC), Equatorial Guinea, Eritrea, Gabon, The
Gambia, Guinea, Guinea-Bissau, Liberia, São Tomé and
Príncipe, Zambia, Zimbabwe and the new Sudan/South
Sudan [1].
There are several factors that have potentially impacted
on the progress of these countries and their ability to fully
establish their LF Programme, and launch or scale-up
MDA activities. Many of these countries are among the
poorest in the world according to the United Nations
Human Development Index (HDI), with over half the
countries among the 20 least developed countries in the
world (i.e. CAR, Chad, DRC, Eritrea, The Gambia, Guinea,
Guinea-Bissau, Liberia, Sudan/South Sudan, Zimbabwe)
[14]. Many are conflict or post-conflict countries with fra-
gile health systems, inadequate transport infrastructure,
populations which are difficult to access and with a high
number of internally displaced people [14,15]. Addition-
ally, half of the countries are co-endemic with Loa loa, an-
other filarial parasite that can cause severe adverse events
(SAEs) after treatment with ivermectin [16-18]. This is asignificant impediment for countries in West and Central
Africa, particularly in DRC where both diseases are
considered to be highly endemic [19].
These challenges pose major barriers for national LF
programmes. Whilst twice yearly treatment of albendazole
alone has been recommended as an alternative drug re-
gime in LF/L. loa co-endemic areas where ivermectin can-
not be safely used on a mass scale [20], it is imperative
that additional strategies such as vector control, and links
with large scale malaria programmes are considered, espe-
cially as interventions such as insecticide treated and/or
long lasting insecticidal nets (ITNs/LLINs) [21] and in-
door residual spraying (IRS) [22] for malaria control, have
shown to impact LF in a variety of ecological settings
where Anopheles are the primary vectors [23-31]. WHO is
advocating for integrated vector management (IVM),
encouraging better linkages between LF and malaria
programmes [32], and has recently developed provisional
strategies for interrupting LF in loiasis-endemic areas
which involves vector control [18].
The objective of this study was to examine the magni-
tude and geographical extent of recent deployment of
ITNs/ LLINs and IRS activities in 17 African countries
to determine the potential additive impact of vector con-
trol interventions on LF and their potential contribution
to the global goal of LF elimination by 2020.
Methods
Data sources
National data on the population at risk of LF and the L.
loa co-endemicity status was obtained from the WHO
Progress Report [1] for Angola, CAR, Chad, Congo,
DRC, Eritrea, Equatorial Guinea, Gabon, The Gambia,
Guinea, Guinea Bissau, Liberia, São Tomé and Príncipe,
Sudan/South Sudan, Zambia, and Zimbabwe. The African
map of LF developed by Lindsay and Thomas [7] was used
to highlight the distribution of microfilaria (Mf) preva-
lence levels of 20-40%, and >40% across the continent,
specifically in the 17 countries and in relation to L. Loa
prevalence. The recent loiasis risk map for Africa defined
from extensive field surveys of eye worm history
[16,33,34], was used to highlight the distribution of
L.loa prevalence levels of 20-40%, and >40% includ-
ing the risk of SAEs. The LF and L. Loa maps were
imported and digitised in the geographical information
system software ArcGIS 10 (ESRI, Redlands, CA) to define
the specific prevalence distributions, examine the extent
of geographical overlap and to identify areas that would
benefit from vector control.
National and sub-national data collected between 2000
and 2010 with specific geographical information on
mosquito bed nets, ITNs and IRS were obtained from
published literature, national reports, surveys and datasets
from public sources including the WHO, Demographic
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and Multiple Indicator Cluster Surveys (MICS), World
Malaria Reports, Roll Back Malaria (RBM) and President’s
Malaria Initiative (PMI) websites [35-41]. Specifically,
household-level data from DHS and MIS cluster surveys
[38,39] with information on the geographical coordinates
of each cluster (i.e. geo-referenced), were obtained to
examine the finer spatial distribution of vector control
interventions for malaria relating to household owner-
ship and number of mosquito bed nets, and presence
of IRS activities.
National and sub-national analyses
National data on the percentage of households owning
at least one ITN and percentage of IRS coverage be-
tween 2000 and 2010 were summarised [35,36]. The
differences between urban and rural populations and the
percentage of households with at least one type of mos-
quito bed net, at least one ITN and the percentage of
children <5 years of age who had slept under any net the
night prior to the survey were summarised and tabulated
for each country based on all DHS, MIS and MICS
reports available [38,39]. Sub-national data were based
on recent provincial/state reports and survey data avail-
able from 2005 and used to create maps using software
ArcGIS 10 (ESRI, Redlands, CA). The percentage of
households with very low (<25%), low (25-50%), medium
(50-75%) and high (>75%) coverage of at least one bed
net (any type), at least one ITN and the presence of IRS
activities were highlighted for each country with the data
available. DHS geo-referenced cluster data (latitude and
longitude coordinates) in geographically defined areas,
with information on vector control activities were also
used to map the spatial distributions of bed nets (any
type) and IRS activities on a finer scale.
Results
National data analysis
The estimated population at risk of LF is summarised in
Table 1. Collectively these countries account for more
than 100 million people at risk, representing approxi-
mately half of the estimated burden across Africa. Geo-
graphically, these countries cover vast, often remote,
areas of the continent over more than 10 million km2
as shown in Figure 1a. The geographical limits of LF
mapped in Figure 1b highlight the widespread nature of
the disease with most of the 17 countries highly endemic
with Mf prevalence estimates >40%. The distribution of
L. loa was mainly found in Central and West Africa
(Figure 1c). In total 8 countries are considered to be
co-endemic with W. bancrofti and L.loa with the greatest
risk of L. loa and SAEs in CAR, Congo, DRC, Equatorial
Guinea, Gabon and the new country of South Sudan
(Figure 1d).Data collected from the recent World Malaria Reports
[35,36] estimate that the proportion of households
owning at least one ITN (based on modeled estimates
between 2000 and 2010), had increased three-fold overall
since 2005 (Table 1), however, there was great variation
between the 17 countries as highlighted in Figure 2a.
Between 2000 and 2004, the average national ITN cover-
age was 10.6% for all countries and ranged from 1.0 to
58.2%, with the lowest coverage in Guinea 1.0%, Congo,
Liberia and Sudan 2%, and the highest in The Gambia
24%, São Tomé and Príncipe 29% and Eritrea 58%. Data
from between 2005 and 2010, showed the average national
ITN coverage was 32.4% for all countries with a range
from 6.2 to 68.7%, with the lowest coverages in Guinea
6.2%, Congo 7.7% and Chad 7.2% and the highest in
Eritrea 68.7%, São Tomé and Príncipe 59%, Zambia
59% (Table 1, Figure 2a).
Similarly for IRS, the data available in the World Malaria
Reports indicate that the proportion of people coverage by
IRS differed over time and between countries as shown in
Table 1 [35,36]. Overall, there were fewer countries receiv-
ing IRS and the coverage was generally low. Between 2000
and 2004, the average national coverage was 6.9% for the
six countries reporting this activity, and coverage ranged
from 0.2% in Angola to 17.3% in Zambia (Figure 2b). This
compared to data between 2005 and 2010, when the aver-
age national IRS coverage was 20.7% for the 10 countries
reporting this activity, and ranged from 0.1% in DRC to
74.3% in São Tomé and Príncipe.
National urban and rural comparisons
DHS, MIS [38] and MICS [39] reports indicate that
differences between urban and rural populations in rela-
tion to the percentage of households with at least one
bed net (any type), an ITN and children <5 years of age
who had slept under any net are shown in Table 2. Over-
all, the highest coverage rates were found in urban areas
except in selected surveys of Angola, Equatorial Guinea,
Eritrea, Liberia and Zambia. Similar to data presented in
Table 1, coverage rates were generally lower for the
period 2000 to 2004 compared with 2005 to 2010. Over-
all, the majority of countries with data from two differ-
ent time periods had a two- to three-fold increase in
coverage over a 5 to 7 year period.
For the period 2000 to 2004, there were limited data
available on the percentage of bed nets (any type) and/or
ITNs [38,39], however, there were 10 surveys reporting
the percentage of children <5 years of age who had slept
under any net, highlighting that the lowest coverage was
in Angola, Eritrea, DRC and Zambia (urban 10.8- 15.0%;
rural 4.7-11.0%) and the highest coverage in Guinea Bissau,
São Tomé and Príncipe and Chad (urban 57.5 - 74.7%; rural
18.6 - 63.4%) (Table 2). The most significant increases in
coverage after this period were the percentages of children
Table 1 Summary of disease data and main vector control interventions 2000 to 2010
Country Risk of LF Loa loa endemic Households (%) at least one ITN IRS coverage (%)
2000-04 2005-10 2000-04 2005-10
Angola 12090000 Yes 6.0 17.7 0.2 3.6
CAR 3300000 Yes 4.6 19.7 - -
Chad 7270000 Yes 5.2 7.2 - -
Congo 2600000 Yes 1.8 7.7 - -
DRC 49140000 Yes 2.8 26.5 - 0.1
Equat. Guinea 420000 Yes 2.2 30.0 8.0 32.2
Eritrea 3577000 No 58.2 68.7 4.5 4.6
Gabon 1290600 Yes 1.8 41.0 - -
Gambia 1200000 No 24.2 43.2 - 35.1
Guinea 6067135 No 1.0 6.2 - 0.4
Guinea-Bissau 1311741 No 14.6 41.2 - -
Liberia 3600000 No 1.8 37.8 - -
STP* 410000 No 29.4 59.0 - 74.3
Sudan - Yes 1.8 17.7 6.9 6.7
Zambia 8780000 No 11.2 59.0 4.4 32.0
Zimbabwe 6000000 No 2.8 35.3 17.3 31.1
*STP=São Tomé and Príncipe.
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67%), in São Tomé and Príncipe (28.2% to 52.3%) and
Zambia (4.7% to 49.3%).
For the period 2005 to 2011, countries with the lowest
coverage of bed nets (any type) included Zimbabwe and
Guinea (urban 27.5 - 34.4%; rural 12.8 - 26.5%) with the
highest in Congo and Guinea Bissau (urban 81.5 - 82%;
rural 68.2 - 77.8%) [38,39]. For ITNs, the lowest cover-
age was in the Congo, Guinea and Zimbabwe (urban 1.0 -
11%; rural 0.3 - 8.0%), and the highest in São Tomé and
Príncipe and Zambia (urban 52.6 - 69.2%; rural 52.4 -
53.7%). Similarly, for children < 5 years of age who had
slept under a bed net [any type], the lowest coverage was
in Angola, Guinea and Zimbabwe (urban 15.7 - 19.2%;
rural 3.2 - 22%) and the highest in Guinea Bissau, The
Gambia, and São Tomé and Príncipe (urban 54.6-79.9%;
rural 67.6-70.5%).
Sub-national mosquito bed net and ITN maps
Maps of provincial and/or state level coverage were
created from the report data [38,39] to highlight the
broad distribution of bed nets (any type) and ITNs
across Angola, CAR, Congo, DRC, The Gambia, Guinea,
Guinea Bissau, Liberia, São Tomé and Príncipe, Zambia
and Zimbabwe from survey data obtained between 2005
and 2011 (Figure 3a,b). No recent provincial and/or state
level data were available from these data sources for
Chad, Equatorial Guinea, Eritrea, Gabon or Sudan.
Overall, higher percentages were found across Congo,
Guinea Bissau, The Gambia, Liberia, São Tomé andPríncipe and Zambia (Figure 3a,b). However, there were
some differences between countries, for example, Congo
had a higher percentage of bed nets (any type) than all
other countries but very low ITNs, whereas Zambia had
a relatively high percentage of both interventions
(Figure 3a, b). In high risk L.loa countries (Figure 1),
there was generally no information available or predom-
inately low percentages of bed nets (any type) and ITNs
reported, except in Congo where there was a very high
(>75%) percentage of bed net use (any type).
Geo-referenced cluster data with information on the
percentage of households with no bed net, one bed net
(any type) and two bed nets (any type) were available for
six countries including, Angola, DRC, Guinea, Liberia,
Zambia, and Zimbabwe [38]. The number of clusters
differed for each country, however, the overall trends
were similar with a high percentage (>50%) of households
reporting no ownership of a bed net (Figure 4a, d). There
was a lower percentage (<25%) of households with one
bed net, however, Liberia and Zambia reported higher
coverages than the other countries (Figure 4b, e). Very few
households in each cluster had two bed nets, with Zambia
reporting the highest coverage (Figure 4c, f).
Sub-national IRS data and maps
Information on IRS activities since 2005 were available
for ten countries, including Angola, DRC, Equatorial
Guinea, Eritrea, The Gambia, Guinea, Liberia, São Tomé
and Príncipe, Zambia, and Zimbabwe. The main sources
were WHO, RBM and PMI reports [37,40,41], and DHS
A Study countries B LF prevalence
C L. Loa prevalence D LF and L. loa co-endemicity 
20-40%
> 40%
20-40%
> 40%
Figure 1 LF and Loa loa prevalence and the extent of co-endemicity in 17 countries. A. Study countries. B. LF prevalence. C. L. loa
prevalence. D. LF and L. loa co-endemicity.
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or no information available from other sources. There
was great variability in the detail of reporting includ-
ing the population covered, geographical extent of ac-
tivities and insecticides used, which mainly included
pyrethroids (lambdacyhalothrin, alphacypermethrin), and/
or organochlorines (DDT), however, carbamates were also
reported in some countries where insecticide resistance
had emerged in key vector Anopheles species [41].
Overall, the most extensive IRS activities were reported
in Angola, Zambia and Zimbabwe. In Angola, IRS with
lambdacyhalothrin was used periodically in selected areas
of central and southern provinces since 2006. In Zambia,
IRS activities were expanded rapidly from 2004 to reach
full geographical coverage using different insecticides
in different regions including lambdacyhalothrin, DDT,
carbamates, and etofenpox. Similarly, Zimbabwe scaled up
IRS activities significantly over the past decade using DDT
and lambdacyhalothrin. The DHS geo-referenced cluster
data on the percentage of households reporting IRS activ-
ities were available for all three countries for the period
2005–2007, and for Angola and Zimbabwe for the years2010–2011 (Figure 5a, b). Comparison between the differ-
ent time periods indicated an increase in IRS activ-
ities in Angola with six clusters from four provinces
reporting >25% IRS activities in 2007, compared with 28
clusters from eight provinces in 2011. Zimbabwe had
higher coverage overall, and 80 clusters from nine
provinces reported >25% IRS in 2005, compared with 95
clusters in 2010. In Zambia, 69 clusters from nine
provinces reported >25% IRS in 2005, however, no DHS
cluster data were available thereafter for comparison.
The island nation of São Tomé and Príncipe, and
Bioko Island of Equatorial Guinea also reported wide-
spread IRS activities. In São Tomé and Príncipe, an IVM
programme was initiated by the Ministry in 2003 which
included IRS, space spraying and larviciding. Between
2005–2007, all districts were targeted with IRS using
alphacypermethrin once a year with a reported coverage
of 94% of households. No detailed reports are available,
however, large-scale IRS activities were expected to
continue until 2009. In Equatorial Guinea, IRS activ-
ities have been focused in Bioko Island covering all
districts since 2004 using by deltamethrin and/or the
A Insecticide-treated nets (ITNs)
B Indoor Residual Spraying (IRS)
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Figure 2 National summaries of the proportion of households with vector control. A. Insecticide-treated nets (ITNs). B. Indoor Residual
Spraying (IRS). Note: Data obtained from the Malaria Report 2010, Chapter 4: Vector Control, Table 4.3 and Annex 5.
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coverage reported.
IRS activities in the other countries report less in
terms of geographical coverage and duration, with little
data or detailed information available in the public do-
main. In DRC, IRS has been limited to heath zones
where mining companies (extractive industries) are op-
erating, mostly in the Katanga Province. In Sudan, IRS
was carried out in targeted irrigated areas and in the
Northern, River Nile and Kassala States. In Eritrea, IRS
has been implemented in most malarious areas since
2004, initially with blanket coverage and then in selective
areas using DDT and the organophosphate, malathion.
In 2007, IRS was reported in nine districts across
three zones of the country covering an estimated 8%
of the population.
In West Africa, Liberia reported IRS activities in 2007–
2008 in camps for internally displaced persons and
refugees, and since 2010 IRS activities have been carried
out in selected counties using DDT and pyrethroids. InGuinea, a survey in 2010 reported 8% of households had
received IRS in the previous 12 months, with the Conakry
Region reporting the highest coverage of 19%, while
other regions with more than 2% IRS coverage included
the mining areas of Boke, Kankan and Faranah. In
The Gambia, a news article highlighted that IRS was
introduced in the country in 2008 and implemented by
local communities in 2009, and specifically launched in
Janjangbureh, Central River Region in 2011, however, no
further details or reports are available.
Discussion
This study provides a broad overview of vector control
activities in the 17 African countries that are yet to start,
or have only recently started MDA implementation for
LF elimination. Overall, the significant scale up of ITNs,
and to a lesser extent IRS, is promising, and it is likely
that these interventions that reduce malaria transmission
[21,22,42-44], have also already impacted on the trans-
mission of W. bancrofti in many co-endemic areas.
Table 2 Urban and rural comparisons of mosquito bed nets and ITNs ownership and usage
Country Year Households (%) with at least one type
of bed net
Households (%) with at least
one ITN
Children (%) < 5 years slept under
any bed net
Urban Rural Urban Rural Urban Rural
Angola 2000 - - - - 10.8 9.6
Angola 2006 34.0 31.3 29.1 25.9 19.2 22.0
Angola 2011 41.5 33.5 39.0 31.8 30.7 25.2
CAR 2000 - - - - 48.2 19.8
CAR 2006 54.0 25.9 26.1 11.2 52.4 21.7
Chad 2004 - - - - 77.2 61.0
Chad 2006 - - - - 57.5 18.6
Congo 2005 82.0 68.3 8.0 8.0 76.8 59.7
Congo 2011 86.4 79.6 18.9 39.7 83.8 76.8
DRC 2001 - - - - 15.0 10.3
DRC 2007 37.8 21.5 12.4 7.1 26.0 14.3
Equat. Guinea - - - - - - -
Eritrea 2002 28.3 37.3 - - 14.3 11.0
Gabon 2000 - - - - - -
The Gambia 2000 - - - - 45.4 35.8
The Gambia 2005 48.5 69.6 34.0 64.0 54.6 67.6
Guinea 2005 27.5 26.5 1.0 0.3 15.7 11.0
Guinea-Bissau 2000 - - - - 74.7 63.4
Guinea-Bissau 2006 81.5 77.8 34.5 48.9 79.9 70.5
Liberia 2007 31.3 29.9 - - - -
Liberia 2009 44.5 52.7 42.0 51.8 25.6 28.2
STP 2000 - - - - 60.4 27.1
STP 2006 58.4 37.3 44.1 25.4 61.8 41.0
STP 2008 75.2 61.1 69.2 52.4 72.9 52.3
Sudan 2000 - - - - 25.8 20.6
Zambia 1999 - - - - 8.5 4.7
Zambia 2001 34.9 23.4 16.1 12.4 21.9 13.7
Zambia 2007 64.3 64.4 52.6 53.7 35.0 32.8
Zambia 2008 66.2 73.6 58.8 63.9 42.8 49.3
Zimbabwe 2005 34.4 12.8 11.0 7.2 16.1 3.2
Zimbabwe 2010 46.9 38.2 23.2 31.6 18.8 11.6
Note: Data are based on DHS, MIS, MIC national survey reports available between 2000 and 2010.
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may be more efficient and cost effective for the new LF
Programmes to develop formal links with national mal-
aria control programmes and include IVM as one of
their key intervention strategies [32]. A recent review
has highlighted several examples of IVM carried out in a
range of ecological settings [9], which suggests that this
integrated approach could be successful in Africa where
the main vectors of malaria and LF are similar Anopheles
species, and transmission may coincide [10,11,45-48]. In
order to achieve this, it is critical that countries take
advantage of the current funding available for malaria,as resources may be declining and the window of
opportunity for vector control may be closing in the
near future.
The reason for the variation in vector control coverage
across the different countries may be due to a number
of factors including the geographical size (e.g. São Tomé
and Príncipe - small islands), and the relative wealth and
political stability of a country (e.g. DRC, Guinea, Angola,
Zimbabwe - post conflict) [14]. It may also be related to
whether a country has an established and active malaria
control programme (e.g. The Gambia - traditional high
net coverage, Eritrea - high bed net coverage) [49-53], or
No data
<25%
25-50%
50-75%
>75%
A  Mosquito bed nets (any type) B Insecticide-treated nets (ITNs)
Figure 3 Sub-national distribution of households in possession of at least one bed net and at least one insecticide-treated net (ITN). A.
mosquito nets (any type). B. Insecticide-treated nets (ITN). Note: Maps based on data from the following survey reports in Angola (MIS 2006–07),
CAR (MICS 2006), Congo (DHS 2005), DRC (DHS 2007), The Gambia (MICS 2005–06), Guinea (DHS 2005), Guinea Bissau (MICS 2006), Liberia (MIS
2009), São Tomé and Príncipe (DHS 2008–09), Zambia (MICS 2008) and Zimbabwe (DHS 2005–06).
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the government and international donors and particu-
larly the Global Fund (e.g. Zambia - significant support
from World Bank) [35,36]. These factors are complex
and interacting, and how the GPELF can use this infor-
mation to take full advantage of the increasing scale up
of ITN and IRS activities, needs to be considered in the
context of the LF endemicity and programmatic capacity
of each country, as it can vary considerably [1,13].A No nets One net (any type)B
D ENo nets One net (any type)
Central Southern Africa
West Africa
Figure 4 Proportion of households per cluster with bed nets (any typ
Africa: D. No net. E. One net F. Two nets.It is possible that a number countries such as The
Gambia, Eritrea and São Tomé and Príncipe may not
need to develop a LF Elimination Programme or imple-
ment MDA at all, as they are small, politically stable, have
established active malaria control programmes, relatively
high bed net coverage and shown limited or no evidence
of LF transmission in the past decade. While The Gambia
has historical evidence of high LF transmission [54-56], it
also has a long history of large scale bed net distribution<25%
25-50%
50-75%
>75%
Two nets (any type)C
F Two nets (any type)
e). Central Southern Africa: A. No net. B. One net. C. Two nets. West
A 2005-2007 B 2010-2011
%
0
<25%
25-50%
50-75%
>75%
Figure 5 Percentage of households reporting indoor residual spraying (IRS) activities. A. 2005–2007. B. 2010–2011. Notes: Maps based on
geo-referenced cluster data collected in Angola (2007, 2011), Zambia (2007), and Zimbabwe (2005, 2010).
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http://www.parasitesandvectors.com/content/6/1/39[52,53], and recent reports suggest that LF is no longer a
public health problem (unpublished data). Eritrea has little
historical evidence [8,56], has no current data on LF, as
programmatic mapping has not started [1], but has a suc-
cessful vector control programme [49-51]. In São Tomé
and Príncipe, historical reports indicate disease presence
[56], and recent IVM activities are likely to have impacted
transmission [35-41,49]. Therefore, it may be more appro-
priate to assess these countries for the interruption of trans-
mission using the new Transmission Assessment Survey
(TAS) developed by WHO [57,58]. Recently, WHO
reassessed nine other countries and compiled sufficient
evidence to reclassify them as non-endemic, thereby redu-
cing the global number of endemic countries to 73 [59].
A similar assessment using TAS as a tool to verify
the lack of transmission in The Gambia, Eritrea and
São Tomé and Príncipe may help ‘shrink the map’, as
well as contribute to considerable cost savings. Similarly,
on Bioko Island, Equatorial Guinea the use of iver-
mectin in onchocerciasis control together with a high
net and IRS use will have been likely to have an addi-
tive impact [60].
Zambia is another country with a well established vec-
tor control programme with relatively high bed net
coverage, and some IRS activities, which also could have
impacted on LF transmission [37,41,49,61,62]. However,
in Zambia the LF Programme recently finalised baseline
mapping and found two thirds of the population at risk
of LF. Overall antigen prevalence rates were low ≤10%,
except in a few selected regions of the country (unpub-
lished data). The first MDA is due to start in early 2013
and together with the ongoing vector control activities,
the LF Programme could see a significant reduction in
transmission in most regions of the country within a
few years. The only concern to note is that there is
already widespread insecticide resistance found in sev-
eral Anopheles species across the country and differ-
ent strategies to overcome this are currently being
developed [41,63].The extent to which insecticide resistance prevents
ITNs and IRS from being effective is not known, espe-
cially in relation to LF transmission. However, given the
increasing geographical spread of resistance to multiple
classes of insecticide across Africa [64-68], there seems
to be another small window of opportunity to maximise
the full potential of these alternative strategies. Alarm-
ingly, almost all of the 17 countries have already reported
some degree of insecticide resistance to one of the main
classes of insecticides, in one of the main Anopheles spe-
cies responsible for malaria transmission. The scope
of this problem is yet to be fully determined, how-
ever, resistance monitoring is becoming increasingly
important among international stakeholders such as
PMI [41], and the development of publicly accessible
up-to-date databases and maps, including the new IR
Mapper [67,68], will help to assess the situation over
time and space along with other programmatic activ-
ities [69-71]. This is particularly important given the
limited availability of vector control tools and the fact that
new products will not be available for some years [72]. It
is also not know what effect insecticide resistance will
have on filarial worm development in Anopheles mosqui-
toes, as in Culex, highly elevated esterases involved in in-
secticide resistance were found to inhibit development of
microfilariae of W.bancrofti in a study in Sri Lanka [73].
The countries facing the greatest challenges are those
that have endured conflict and civil unrest, and have
among the lowest coverage of vector control interventions
such as Congo, Guinea, and DRC [15,35-41]. New LF
programmes in these countries are establishing them-
selves, with significant barriers related to the lack of
public infrastructure, transport networks and trained
health personnel. Malaria control programmes face similar
constraints despite significantly more funding available for
vector control [35,36,40,41]. In large countries such as
DRC, significant geographical factors have been found
to contribute to low bed net coverage in remote, rural
areas [15], which suggests that alternative distribution
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endemic with L. loa and ITNs are one of the main
recommended strategies by WHO [20]. Increased efforts
to boost vector control coverage in high risk L. loa co-
endemic areas is critical, especially as potential alternative
strategies such as twice a year albendazole have to go to
scale whilst the use of doxycycline an anti-Wolbachia
macrofilaricide or adult sterilising agent [74-76], has yet to
be recommended or available for distribution without
medical supervision.
The use of the established and extensive network of
community drug distributors working for the African
Programme for Onchocerciasis Control (APOC) in eight
of the 17 countries may be an entry point to increase
ITN distributions as has been demonstrated in Nigeria
[77,78]. This will benefit both the LF and malaria
programmes, and provide new opportunities for oncho-
cerciasis programmes which may be scaling down due to
their success as they move towards the elimination of
transmission of Onchocerca volvulus [79,80]. Already
many LF Elimination Programmes across Africa use the
community-directed treatment with ivermectin (CDTi)
strategy developed by APOC, as a platform to distribute
MDA [1]. It seems sensible to extend this to include
ITNs and other interventions in the remote hard-to-reach,
co-endemic areas where CDTi already operates [78,81].
Finer scale mapping, using the micro-stratification overlap
mapping (MOM) approach, could be used to identify the
populations most at risk, so that ITNs distributions
can be specifically targeted [19]. However, more col-
laboration, communication and coordination between
the various NTD and malaria vector-borne disease
control programmes is important and becoming an
international priority.
Conclusions
This study highlights that although many African coun-
tries are behind with initiating MDA, and populations
remain at risk, the continued global commitment and
financial support and the expansion of insecticide-based
vector control activities, is promising. The scale-up
of these interventions is unprecedented and provides
a unique opportunity to impact significantly on two major
vector-borne diseases in Africa. It is not beyond the scope
of GPELF in reaching its target of global elimination by
2020, however, more evidence-based data are needed to
firmly establish the association between malaria vector
control activities and the decline in the indicators of trans-
mission of LF, and monitoring and evaluating the impact
of these activities over the next decade will be critical to
its success.
Competing interests
The authors declare that they have no competing interests.Authors’ contributions
LKH and MJB conceived the idea for the study. LKH identified data sources,
developed the study design and collated, mapped and analysed the data.
DHM and MJB contributed to the interpretation of results. LKH wrote the
first draft, and all authors contributed to and read the final version of the
manuscript.Acknowledgements
We acknowledge Dr Kazuyo Ichimori from the World Health Organization
(WHO) for discussions on integrated vector management to control malaria
and lymphatic filariasis. The study was funded from a grant from the
Department for International Development (DFID) and GlaxoSmithKline (GSK)
for research on the elimination of lymphatic filariasis.
Received: 22 December 2012 Accepted: 5 February 2013
Published: 22 February 2013References
1. World Health Organization: Progress report 2000–2009 and strategic plan
2010–2020 of the global programme to eliminate lymphatic filariasis: halfway
towards eliminating lymphatic filariasis. Geneva: WHO/HTM/NTD/PCT/2010.6;
2010.
2. World Health Organization: Global programme to eliminate lymphatic
filariasis: progress report, 2011. Wkly Epidemiol Rec 2012, 87:346–356.
3. Molyneux DH, Nantulya VM: Linking disease control programmes in rural
Africa: a pro-poor strategy to reach Abuja targets and millennium
development goals. BMJ 2004, 328:1129–1132.
4. Molyneux DH, Hotez PJ, Fenwick A, Newman RD, Greenwood B, Sachs J:
Neglected tropical diseases and the Global Fund. Lancet 2009,
373:296–299.
5. Manga L: Vector-control synergies, between ‘Roll Back Malaria’ and the
Global Programme to Eliminate Lymphatic Filariasis, in the African
Region. Ann Trop Med Parasitol 2002, 96(suppl 2):S129–S132.
6. Bockarie MJ, Pedersen EM, White GB, Michael E: Role of vector control in
the global program to eliminate lymphatic filariasis. Annu Rev Entomol
2009, 54:469–487. Review.
7. Lindsay SW, Thomas CJ: Mapping and estimating the population at risk
from lymphatic filariasis in Africa. Trans R Soc Trop Med Hyg 2000,
94:37–45.
8. Sasa M: Human Filariasis - a Global Survey of Epidemiology and Control.
Baltimore, Maryland: University Park Press; 1976.
9. van den Berg H, Kelly-Hope LA, Lindsay SW: Malaria and lymphatic
filariasis: the case for integrated vector management. Lancet Infect Dis
2013, 13:89–94.
10. de Souza DK, Koudou B, Kelly-Hope LA, Wilson MD, Bockarie MJ, Boakye DA:
Diversity and transmission competence in lymphatic filariasis vectors in
West Africa, and the implications for accelerated elimination of
Anopheles-transmitted filariasis. Parasit Vectors 2012, 5:259.
11. Manguin S, Bangs MJ, Pothikasikorn J, Chareonviriyaphap T: Review on
global co-transmission of human Plasmodium species and Wuchereria
bancrofti by Anopheles mosquitoes. Infect Genet Evol 2009, 10:159–177.
12. Raghavan NG: The vectors of human infections by Wuchereria species
in endemic areas and their biology. Bull World Health Organ 1961,
24:177–195.
13. Addiss D: Global Alliance to Eliminate Lymphatic Filariasis. The 6th
Meeting of the Global Alliance to Eliminate Lymphatic Filariasis: A half-
time review of lymphatic filariasis elimination and its integration with
the control of other neglected tropical diseases. Parasit Vectors 2010,
3:100.
14. UNDP: International Human Development Indicators. Available at: http://
hdr.undp.org/en/statistics/.
15. Stanton M, Bockarie MJ, Kelly-Hope LA: Geographical Factors Affecting
Bed Net Ownership, a Tool for the Elimination of Anopheles-Transmitted
Lymphatic Filariasis in Hard-to-Reach Communities. PLoS One 2013,
8:e53755.
16. Zouré HG, Wanji S, Noma M, Amazigo UV, Diggle PJ, Tekle AH, Remme JH:
The geographic distribution of Loa loa in Africa: results of large-scale
implementation of the Rapid Assessment Procedure for Loiasis
(RAPLOA). PLoS Negl Trop Dis 2011, 5:e1210.
17. Boussinesq M: Loiasis. Ann Trop Med Parasit 2006, 100:715–731.
Kelly-Hope et al. Parasites & Vectors 2013, 6:39 Page 11 of 12
http://www.parasitesandvectors.com/content/6/1/3918. Gardon J, Gardon-Wendel M, Demanga ND, Kamgno J, Chippaux JP, et al:
Serious reactions after mass treatment of onchocerciasis with ivermectin
in an area endemic for Loa loa infection. Lancet 1997, 1997(350):18–22.
19. Kelly-Hope LA, Thomas BC, Bockarie MJ, Molyneux DH: Lymphatic filariasis
in the Democratic Republic of Congo; micro-stratification overlap
mapping (MOM) as a prerequisite for control and surveillance. Parasit
Vectors 2011, 4:178.
20. World Health Organization: Provisional strategy for interrupting Lymphatic
filariasis transmission in loiasis-endemic countries, Report of the meeting on
lymphatic filariasis, malaria and integrated vector management. Accra,
Ghana, 5–9 March 2012. 2012. WHO/HTM/NTD/PCT/2012.6.
21. Lengeler C: Insecticide-treated bed nets and curtains for preventing
malaria. Cochrane Database Syst Rev 2004, (2):Art. No CD000363.
doi:10.1002/14651858.CD000363.pub2.
22. Pluess B, Tanser FC, Lengeler C, Sharp BL: Indoor residual spraying for
preventing malaria. Cochrane Database Syst Rev 2010, (4):Art. No.:
CD006657. doi:10.1002/14651858.CD006657.pub2.
23. Ashton RA, Kyabayinze DJ, Opio T, Auma A, Edwards T, Matwale G, Onapa
A, Brooker S, Kolaczinski JH: The impact of mass drug administration and
long-lasting insecticidal net distribution on Wuchereria bancrofti
infection in humans and mosquitoes: an observational study in northern
Uganda. Parasit Vectors 2011, 4:134.
24. Emukah E, Graves PM, Mosher AW, Rakers L, Miri E, Chidiebere N, Kenrick N,
Josephine O, Njideka OT, Richards FO: Long lasting insecticidal nets alone can
reduce transmission of lymphatic filariasis in south east Nigeria, Abstract Book
American Society of Tropical Medicine and Hygiene 58th Annual Meeting:
November18-22, 2009, Washington DC.
25. Bockarie MJ, Tavul L, Kastens W, Michael E, Kazura JW: Impact of untreated
bednets on prevalence of Wuchereria bancrofti transmitted by Anopheles
farauti in Papua New Guinea. Med Vet Entomol 2002, 16:116–119.
26. Pedersen EM, Mukoko DA: Impact of insecticide-treated materials on
filaria transmission by the various species of vector mosquito in Africa.
Ann Trop Med Parasitol 2002, 96(Suppl 2):S91–S95.
27. Bøgh C, Pedersen EM, Mukoko DA, Ouma JH: Permethrin-impregnated
bednet effects on resting and feeding behaviour of lymphatic filariasis
vector mosquitoes in Kenya. Med Vet Entomol 1998, 12:52–59.
28. Burkot TR, Garner P, Paru R, et al: Effects of untreated bed nets on the
transmission of Plasmodium falciparum, P. vivax and Wuchereria bancrofti
in Papua New Guinea. Trans R Soc Trop Med Hyg 1990, 4:773–779.
29. Prybylski D, Alto WA, Mengeap S, Odaibaiyue S: Introduction of an
integrated community-based bancroftian filariasis control program into
the Mt Bosavi region of the Southern Highlands of Papua New Guinea.
PNG Med J 1994, 37:82–89.
30. Webber R: Eradication of Wuchereria bancrofti through vector control.
Trans R Soc Trop Med Hyg 1979, 76:722–724.
31. Webber RH: The natural decline of Wuchereria bancrofti infection in a
vector control situation in the Solomon Islands. Trans R Soc Trop Med Hyg
1977, 71:396–400.
32. World Health Organization: WHO position statement on integrated vector
management to control malaria and lymphatic filariasis. Wkly Epidemiol
Rec 2011, 86:121–127.
33. Wanji S, Takougang I, Yenshu EV, Meremikwu M, Enyong P, Braide E, et al:
Rapid Assessment Procedures for Loiasis. Report of a Multi-centre study, UNDP/
World Bank/WHO Special Programme for Research and Training in Tropical
Diseases TDR/IDE/RP/RAPL/01.1 2001.
34. Kelly-Hope LA, Bockarie MJ, Molyneux DH: Loa loa ecology in central
Africa: role of the Congo River system. PLoS Negl Trop Dis 2012, 6:e1605.
35. World Health Organization: World Malaria Report 2010, WHO Global Malaria
Programme 2010. Available at [http://www.who.int/malaria/
world_malaria_report_2010/en/index.html]
36. World Health Organization: World Malaria Report 2011, WHO Global Malaria
Programme 2011. Available at [http://www.who.int/malaria/
world_malaria_report_2011/en/]
37. World Health Organization: Implementation of Indoor Residual Spraying of
Insecticides for Malaria Control in the World Health Organization African Region
Report. World Health Organization for Africa; 2007. Available at http://www.afro.
who.int/en/clusters-a-programmes/dpc/malaria/mal-publications.html.
38. MEASURE DHS: Demographic and Health Surveys. Available at [http://
www.measuredhs.com/]
39. UNICEF: Statistics and Monitoring. Multiple Indicator Cluster Surveys
(MICS)., [http://www.unicef.org/statistics/index_24302.html]40. Roll Back Malaria: Malaria Country Facts., [http://www.rbm.who.int/]
41. President’s Malaria Initiative: Malaria Operational Plans. [http://www.pmi.
gov/index.html]
42. O'Meara WP, Mangeni JN, Steketee R, Greenwood B: Changes in the
burden of malaria in sub-Saharan Africa. Lancet Infect Dis 2010,
10:545–555.
43. Shaukat AM, Breman JG, McKenzie FE: Using the entomological
inoculation rate to assess the impact of vector control on malaria
parasite transmission and elimination. Malaria J 2010, 9:122.
44. Mabaso ML, Sharp B, Lengeler C: Historical review of malarial control in
southern African with emphasis on the use of indoor residual house-
spraying. Trop Med Int Health 2004, 9:846–856.
45. Sinka ME, Bangs MJ, Manguin S, Coetzee M, Mbogo CM, et al: The
dominant Anopheles vectors of human malaria in Africa, Europe and the
Middle East: occurrence data, distribution maps and bionomic précis.
Parasit Vectors 2010, 3:117.
46. Kelly-Hope LA, McKenzie FE: The multiplicity of malaria transmission: a
review of entomological inoculation rate measurements and methods
across sub-Saharan Africa. Malaria J 2009, 8:19.
47. Muirhead-Thomson RC: Inter-relations between filarial and malarial
infections in Anopheles gambiae. Nature 1953, 172:352–353.
48. Njenga SM, Mwandawiro CS, Wmae CN, Mukoko DA, Omar AA, et al:
Sustained reduction in prevalence of lymphatic filariasis infection in
spite of missed rounds of mass drug administration in an area under
mosquito nets for malaria control. Parasit Vectors 2011, 4:90.
49. Newman RD: Malaria control beyond 2010. BMJ 2010, 340:c2714.
50. Yukich JO, Zerom M, Ghebremeskel T, Tediosi F, Lengeler C: Costs and
cost-effectiveness of vector control in Eritrea using insecticide-treated
bed nets. Malaria J 2009, 8:51.
51. Mufunda J, Nyarango P, Usman A, Gebremeskel T, Mebrahtu G,
Ogbamariam A, Kosia A, Ghebrat Y, Gebresillosie S, Goitom S, Araya E,
Andemichael G, Gebremichael A: Roll back malaria – an African success
story in Eritrea. S Afr Med J 2007, 97:46–50.
52. Cham MK, D’Alessandro U, Todd J, Bennett S, Fegan G, Cham BA,
Greenwood BM: Implementing a nationwide insecticide-impregnated
bednet programme in The Gambia. Health Policy Plann 1996, 11:292–298.
53. Snow RW, Lindsay SW, Hayes RJ, Greenwood BM: Permethrin-treated bed
nets (mosquito nets) prevent malaria in Gambian children. Trans R Soc
Trop Med Hyg 1988, 82:838–842.
54. McFadzean JA: Filariasis in Gambia and Casamance, West Africa. Trans R
Soc Trop Med Hyg 1954, 48:267–273.
55. McGregoria IA, Hawking F, Smith DA: The control of filariasis with
hetrazan; a field trial in a rural village (Keneba) in the Gambia. Br Med J
1952, 2:908–911.
56. Hawking F: The distribution of human filariasis throughout the world. Part III.
Africa. World Health Organization; 1977. WHO/FIL/74.124.
57. Work Health Organization: Monitoring and epidemiological assessment of
mass drug administration in the global programme to eliminate
lymphatic filariasis: a manual for national elimination programmes.
2010, WHO/HTM/NTD/PCT/2011.4.
58. Work Health Organization: Transmission assessment surveys in the Global
Programme to Eliminate Lymphatic Filariasis: WHO position statement.
Wkly Epidemiol Rec 2012, 87:478–482.
59. World Health Organization: Global programme to eliminate lymphatic
filariasis. Wkly Epidemiol Rec 2010, 85:365–372.
60. Kyelem D, Medlock J, Sanou S, Bonkoungou M, Boatin B, Molyneux DH:
Short communication: impact of long-term (14 years) bi-annual
ivermectin treatment on Wuchereria bancrofti microfilaraemia. Trop Med
Int Health 2005, 10:1002–1004.
61. Chizema-Kawesha E, Miller JM, Steketee RW, Mukonka VM, Mukuka C,
Mohamed AD, Miti SK, Campbell CC: Scaling Up Malaria Control in
Zambia: Progress and Impact 2005–2008. Am J Trop Med Hyg 2010,
83:480–488.
62. Steketee RW, Sipilanyambe N, Chimumbwa J, Banda JJ, Mohamed A, Miller
J, Basu S, Miti SK, Campbell CC: National malaria control and scaling up
for impact: the Zambia experience through 2006. Am J Trop Med Hyg
2008, 79:45.
63. Chanda E, Hemingway J, Kleinschmidt I, Rehman AM, Ramdeen V, Phiri FN,
Coetzer S, Mthembu D, Shinondo CJ, Chizema-Kawesha E, Kamuliwo M,
Mukonka V, Baboo KS, Coleman M: Insecticide Resistance and the Future
of Malaria Control in Zambia. PLoS One 2011, 6:e24336.
Kelly-Hope et al. Parasites & Vectors 2013, 6:39 Page 12 of 12
http://www.parasitesandvectors.com/content/6/1/3964. Ranson H, N’guessan R, Lines J, Moiroux N, Nkuni Z, Corbel V: Pyrethroid
resistance in African anopheline mosquitoes: what are the implications
for malaria control? Trends Parasitol 2011, 27:91–98.
65. African Network for Vector Resistance: Atlas of insecticide resistance in
malaria vectors of the WHO African region. Harare: World Health Organization
Regional Office for Africa; 2005.
66. Yewhalaw D, Wassie F, Steurbaut W, Spanoghe P, van Bortel W, Denis L,
Tessema D, Getachew Y, Coosemans M, Duchateau L, et al: Multiple
Insecticide Resistance: An Impediment to Insecticide-Based Malaria
Vector Control Program. PLoS One 2011, 6:e16066.
67. Mapper IR: Mapping insecticide resistance in malaria vectors. [http://
www.irmapper.com/]
68. VectorBase: Bioinformatics Resource for Invertebrate Vectors of Human
Pathogens. IRBase., [https://www.vectorbase.org/content/irbase]
69. Kelly-Hope L, Ranson H, Hemingway J: Lessons from the past: managing
insecticide resistance in malaria control and eradication programmes.
Lancet Infect Dis 2008, 8:387–389.
70. Insecticide Resistance Action Committee (IRAC): Prevention and
management of insecticide resistance in vectors of public health
importance. [http://www.irac-online.org/teams/public-health/]
71. Bass C, Nikou D, Vontas J, Donnelly MJ, Williamson MS, Field LM: The Vector
Population Monitoring Tool (VPMT): High-Throughput DNA-Based
Diagnostics for the Monitoring of Mosquito Vector Populations. Malar
Res Treat 2010, 2010:190434.
72. Hemingway J, Beaty BJ, Rowland M, Scott TW, Sharp BL: The Innovative
Vector Control Consortium: improved control of mosquito-borne
diseases. Trends Parasitol 2006, 22:308–312.
73. McCarroll L, Paton MG, Karunaratne SHPP, Jayasuryia HTR, Kalpage KSP,
Hemingway J: Insecticides and mosquito-borne disease. Nature 2000,
407:961–996.
74. Tamarozzi F, Tendongfor N, Enyong PA, Esum M, Faragher B, Wanji S, Taylor
MJ: Long term impact of large scale community-directed delivery of
doxycycline for the treatment of onchocerciasis. Parasit Vectors 2012, 5:53.
75. Hoerauf A, Pfarr K, Mand S, Debrah AY, Specht S: Filariasis in Africa–
treatment challenges and prospects. Clin Microbiol Infect 2011, 17:977–985.
76. Wanji S, Tendongfor N, Nji T, Esum M, Che JN, Nkwescheu A, Alassa F,
Kamnang G, Enyong PA, Taylor MJ, Hoerauf A, Taylor DW: Community-
directed delivery of doxycycline for the treatment of onchocerciasis in
areas of co-endemicity with loiasis in Cameroon. Parasit Vectors 2009, 2:39.
77. Blackburn BG, Eigege A, Gotau H, Gerlong G, Miri E, Hawley WA, Mathieu E,
Richards F: Successful integration of insecticide-treated bed net
distribution with mass drug administration in Central Nigeria. Am J Trop
Med Hyg 2006, 75:650–655.
78. The CDI Study Group: Community-directed interventions for priority
health problems in Africa: results of a multicountry study. Bull World
Health Organ 2010, 88:509–518.
79. Diawara L, Troare M, Badji A, Issan Y, Doumbia K, Goita SF, Konate L,
Miunkoro K, Sarr MD, Seck AF, Toe L, Toure S, Remme JHF: Feasibility of
onchocerciasis elimination with ivermectin treatment in endemic foci in
Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis
2009, 3:e497.
80. Tekle A, Elhassan E, Isiyaku S, Amazigo UV, Bush S, Noma M, Cousens S,
Abiose A, Remme JH: Impact of long-term treatment of onchocerciasis
with ivermectin in Kaduna State, Nigeria: first evidence of the potential
for elimination in the operational area of the African Programme for
Onchocerciasis Control. Parasit Vectors 2012, 5:28.
81. Amazigo UV, Leak SGA, Zoure HGM, Njepuome N, Lusamba-Dikassa PS:
Community-driven interventions can revolutionise control of neglected
tropical diseases. Trends Parasitol 2012, 28:231–238.
doi:10.1186/1756-3305-6-39
Cite this article as: Kelly-Hope et al.: Can malaria vector control
accelerate the interruption of lymphatic filariasis transmission in Africa;
capturing a window of opportunity?. Parasites & Vectors 2013 6:39.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
